As a result, the Ontario laboratory`s capacity to perform DNA analysis has increased, while quebec`s capacity has remained relatively constant. The number of DNA profiles contained in the NDDB has steadily increased since its inception in 2000 and the number of investigations supported by the NDDB increased by 47% during the period under review. In order to determine whether PS-BCA activities remain necessary, the evaluation examined the reasons for the BCA activity in the broader context of DNA analysis and the national DNA base. and, in general, the need for ps program activities. 5.33 Wen reviewed the RCMP`s cost per application for biology services, but found that the costs were underestimated, as the calculations did not take into account all the work performed. As a result, the RCMP is unable to provide information on the actual costs it incurs in providing this service to other police forces. From 2013-14 to 2017-18, SP funding covered an annual average of approximately 30% and 43% of the DNA testing costs of forensic laboratories in Ontario and Quebec, respectively, according to financial information provided by recipients. This is comparable to the 46% of costs incurred for other provinces and territories under BCAA cost-sharing agreements. It should be noted that BCAAs are designed to meet fluctuations in service demand, while funding for Ontario and Quebec remains the same regardless of the number of DNA samples processed. Funding from Ontario and Quebec has not changed since 2010. In recognition of the value of DNA analysis, the DNA Identification ActFootnote 3 was passed in 1998 and in 2000 the government created the National DNA Data Bank. The Royal Canadian Police (RCMP) manages the database.
The use of DNA for identification purposes in Canada is governed by the DNA Identification Act of 1998 (the Act). Despite the fact that, since the late 1980s, DNA analysis has been used throughout the criminal justice system in Canada, there was no national coordination at that time that allowed law enforcement to take full advantage of advances in DNA technology. . . .